Hereditary angioedema (HAE) is a genetic disorder that causes episodes of extreme swelling (angioedema), commonly in the face, hands, feet, digestive tract, or upper airways. Symptoms may begin ...

Hereditary angioedema is characterized by unpredictable swelling involving the face, oropharynx, extremities, or abdomen, without hives or pruritus. Laryngeal attacks carry a risk of asphyxiation, ...

KalVista's lead asset, sebetralstat, is nearing FDA approval, targeting hereditary angioedema with a first-in-class oral treatment, presenting a significant market opportunity. Strong financial ...

Symptoms of a severe allergic reaction can ... instead of every 2 weeks. People with hereditary angioedema (HAE) have low levels of the C1 inhibitor protein. This is important in helping to ...

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Mean HAE attack rates fell by 62% for the full cohort and by 71% for patients with poorly controlled disease by week 16 of donidalorsen treatment. Mean Hereditary Angioedema Control Test (AECT ...